Table1_Cellular Senescence-Related Genes: Predicting Prognosis in Gastric Cancer.DOCX (17.2 kB)
Download file

Table1_Cellular Senescence-Related Genes: Predicting Prognosis in Gastric Cancer.DOCX

Download (17.2 kB)
posted on 2022-06-01, 04:40 authored by Longfei Dai, Xu Wang, Tao Bai, Jianjun Liu, Bo Chen, Wenqi Yang

Our study aimed to explore the effect of cellular senescence and to find potential therapeutic strategies for gastric cancer. Cellular senescence-related genes were acquired from the CellAge database, while gastric cancer data were obtained from GEO and TCGA databases. SMARCA4 had the highest mutation frequency (6%), and it was linked to higher overall survival (OS) and progression-free survival (PFS). The gastric cancer data in TCGA database served as a training set to construct a prognostic risk score signature, and GEO data were used as a testing set to validate the accuracy of the signature. Patients with the low-risk score group had a longer survival time, while the high-risk score group is the opposite. Patients with low-risk scores had higher immune infiltration and active immune-related pathways. The results of drug sensitivity analysis and the TIDE algorithm showed that the low-risk score group was more susceptible to chemotherapy and immunotherapy. Most patients with mutation genes had a lower risk score than the wild type. Therefore, the risk score signature with cellular senescence-related genes can predict gastric cancer prognosis and identify gastric cancer patients who are sensitive to chemotherapy and immunotherapy.